Want to know how much opioid settlement money your city, county, or state has received so far? Or how much they’re expecting in the future? Use our new searchable database to find out.
A mathematical model designed to direct spending of opioid settlement funds is at the center of a debate over whether to invest in technology to guide long-term decisions or focus on the immediate needs of people in addiction.
The four-page bill lists how states should spend settlement money, but it doesn’t specify consequences for flouting the rules or name who is in charge of monitoring compliance.
An advisory group formed to help Michigan tackle high rates of opioid overdoses in communities of color has been disbanded by Democratic Gov. Gretchen Whitmer’s administration, leading to hard feelings.
In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.
As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?
Some states haven’t begun using opioid settlement funds intended to help curb the opioid epidemic. Meanwhile, more than 100,000 Americans died of an overdose last year.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma — which marketed OxyContin — could claim immunity from future lawsuits without claiming bankruptcy.
Some gubernatorial candidates are sparring over bragging rights for their state’s share of $50 billion in opioid settlement funds. Many of the candidates are attorneys general who pursued the lawsuits that produced the payouts.